GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab

Magnetic Resonance Imaging

Volumn 31, Issue 4, 2013, Pages 618-623

  Hsu, Yu Han H ^a   Ferl, Gregory Z ^b   Ng, Chee M ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DCE MRI data analysis; GPU; Parallel computing

Indexed keywords

BEVACIZUMAB;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BLOOD VESSEL PERMEABILITY; COMPARTMENT MODEL; COMPUTER SYSTEM; DATA ANALYSIS; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; GRAPHICS PROCESSING UNIT; HUMAN; IMAGE PROCESSING; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; MEAN RESIDENCE TIME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS;

ALGORITHMS; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN NEOPLASMS; COMPUTER GRAPHICS; CONTRAST MEDIA; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KINETICS; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84876154750     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.09.007     Document Type: Article

References (19)

1. O'Connor J.P., Jackson A., Parker G.J., Jayson G.C. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007, 96(2):189-195.
2. Zweifel M., Padhani A.R. Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?. Eur J Nucl Med Mol Imaging 2010, 37(Suppl. 1):S164-S182.
3. O'Connor J.P., Jackson A., Parker G.J., Roberts C., Jayson G.C. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 2012, 9(3):167-177.
4. Ferl G.Z., Port R.E. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data. Clin Pharmacol Ther 2012, 92(1):118-124.
5. Ferl G.Z., Xu L., Friesenhahn M., Bernstein L.J., Barboriak D.P., Port R.E. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010, 63(5):1366-1375.
6. Leach M.O., Brindle K.M., Evelhoch J.L., Griffiths J.R., Horsman M.R., Jackson A., et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005, 92(9):1599-1610.
7. Port R.E., Knopp M.V., Hoffmann U., Milker-Zabel S., Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 1999, 10(3):233-241.
8. Port R.E., Bernstein L.J., Barboriak D.P., Xu L., Roberts T.P.L., van Bruggen N. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010, 64(2):408-417.
9. Vredenburgh J.J., Desjardins A., Herndon J.E., Dowell J.M., Reardon D.A., Quinn J.A., et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 2007, 13(4):1253-1259.
10. Stone S.S., Haldar J.P., Tsao S.C., Hwu W.M., Sutton B.P., Liang Z.P. Accelerating advanced MRI reconstructions on GPUs. J Parallel Distrib Comput 2008, 68(10):1307-1318.
11. Shams R., Sadeghi P., Kennedy R.A., Hartley R.I. A survey of medical image registration on multicore and the GPU. IEEE Signal Processing Magazine 2010, 27(2):50-60.
12. Bluml S., Schad L.R., Stepanow B., Lorenz W.J. Spin-lattice relaxation-time measurement by means of a turboflash technique. Magn Reson Med 1993, 30(3):289-295.
13. Deoni S.C.L., Rutt B.K., Peters T.M. Rapid combined T-1 and T-2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003, 49(3):515-526.
14. Martinez W.L., Martinez A.R. Computational statistics handbook with MATLAB 2008, Chapman & Hall/CRC, Boca Raton, FL, [xxiii, 767 p. p].
15. Mays J.E., Birch J.B. Smoothing for small samples with model misspecification: nonparametric and semiparametric concerns. J Appl Stat 2002, 29(7):1023-1045.
16. Fan X., Karczmar G.S. A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study. Magn Reson Med 2009, 62(1):229-239.
17. Rescigno A., Segre G. Drug and tracer kinetics 1966, Blaisdell Pub. Co., Waltham, MA.
18. Ferl G.Z. DATforDCEMRI: an R package for deconvolution analysis and visualization of DCE-MRI data. J Stat Software 2011, 44(3):1-18.
19. Sanders J., Kandrot E. CUDA by example: an introduction to general-purpose GPU programming 2011, Addison-Wesley, Upper Saddle River, NJ, [xix, 290 p. p].